Cargando...
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
This phase II study was conducted to determine the efficacy and toxicity of a gemcitabine (GEM) and oxaliplatin (OX) chemotherapy protocol in patients with unresectable biliary tract cancer (BTC). Patients were treated with GEM 1000 mg m(−2) (30 min infusion) on days 1, 8, 15, and OX 100 mg m(−2) (2...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360533/ https://ncbi.nlm.nih.gov/pubmed/16969352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603334 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|